Alkeon Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History

Alkeon Capital Management LLC

$47.1 Billion
Q1 2025

A detailed history of Alkeon Capital Management LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 4,004,096 shares of ORIC stock, worth $44.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,004,096

Previous 3,904,096 2.56%

Holding current value

$44.6 Million

Previous $31.5 Million 29.09%

% of portfolio

0.05%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$5.58 - $12.54 $558,000 - $1.25 Million	100,000 Added 2.56%	4,004,096 $22.3 Million
Q3 2024 Nov 13, 2024	BUY	$7.52 - $11.9 $752,000 - $1.19 Million	100,000 Added 2.63%	3,904,096 $40 Million
Q2 2024 Aug 13, 2024	BUY	$6.63 - $12.93 $663,000 - $1.29 Million	100,000 Added 2.7%	3,804,096 $26.9 Million
Q1 2024 May 14, 2024	BUY	$8.04 - $16.03 $803,999 - $1.6 Million	100,000 Added 2.77%	3,704,096 $50.9 Million
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $675,205 - $1.18 Million	124,807 Added 3.59%	3,604,096 $33.2 Million
Q3 2023 Nov 13, 2023	BUY	$6.05 - $9.28 $3.03 Million - $4.64 Million	500,000 Added 16.78%	3,479,289 $21 Million
Q2 2023 Aug 11, 2023	BUY	$4.95 - $8.4 $2.87 Million - $4.87 Million	580,037 Added 24.18%	2,979,289 $23.1 Million
Q4 2022 Feb 13, 2023	BUY	$2.41 - $5.89 $704,404 - $1.72 Million	292,284 Added 13.87%	2,399,252 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $540,000 - $1.41 Million	200,000 Added 10.49%	2,106,968 $9.44 Million
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $2.18 Million - $7.73 Million	480,000 Added 33.64%	1,906,968 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $5.16 Million - $8.73 Million	429,979 Added 43.13%	1,426,968 $21 Million
Q2 2021 Aug 16, 2021	SELL	$17.37 - $25.34 $18,620 - $27,164	-1,072 Reduced 0.11%	996,989 $17.6 Million
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $2.37 Million - $3.69 Million	100,000 Added 11.14%	998,061 $24.5 Million
Q4 2020 Feb 16, 2021	BUY	$20.32 - $39.8 $12.1 Million - $23.7 Million	595,000 Added 196.33%	898,061 $30.4 Million
Q3 2020 Nov 16, 2020	BUY	$19.5 - $31.26 $5.91 Million - $9.47 Million	303,061 New	303,061 $7.58 Million

Others Institutions Holding ORIC

# of Institutions

147

Shares Held

75.9M

Call Options Held

11.3K

Put Options Held

2.7K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $441M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Account

Alkeon Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History